Drenth JP - Search Results

1

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts.

Wijnands TF, Schoenemeier B, Potthoff A, Gevers TJ, Groenewoud H, Gebel MJ, Rifai K, Manns MP, Drenth JP. Wijnands TF, et al. Among authors: drenth jp. United European Gastroenterol J. 2018 Jul;6(6):919-925. doi: 10.1177/2050640618764940. Epub 2018 Mar 8. United European Gastroenterol J. 2018. PMID: 30023070 Free PMC article.

2

Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy.

Kok KF, van Soest H, van Herwaarden AE, van Oijen MG, Boland GJ, Halangk J, Berg T, de Vries RA, Drenth JP. Kok KF, et al. Among authors: drenth jp. Eur J Gastroenterol Hepatol. 2010 Jul;22(7):808-12. doi: 10.1097/MEG.0b013e3283320113. Eur J Gastroenterol Hepatol. 2010. PMID: 19794310

3

Somatostatin analogues for treatment of polycystic liver disease.

Gevers TJ, Drenth JP. Gevers TJ, et al. Among authors: drenth jp. Curr Opin Gastroenterol. 2011 May;27(3):294-300. doi: 10.1097/MOG.0b013e328343433f. Curr Opin Gastroenterol. 2011. PMID: 21191289 Review.

4

Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid.

Kuiper EM, Hansen BE, Adang RP, van Nieuwkerk CM, Timmer R, Drenth JP, Spoelstra P, Brouwer HT, Kuyvenhoven JP, van Buuren HR; Dutch PBC Study Group. Kuiper EM, et al. Among authors: drenth jp. Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1495-502. doi: 10.1097/MEG.0b013e32834059e7. Eur J Gastroenterol Hepatol. 2010. PMID: 21389798

5

Low prevalence of cardiac valve abnormalities in patients with autosomal dominant polycystic liver disease.

Gevers TJ, de Koning DB, van Dijk AP, Drenth JP. Gevers TJ, et al. Among authors: drenth jp. Liver Int. 2012 Apr;32(4):690-2. doi: 10.1111/j.1478-3231.2011.02683.x. Epub 2011 Nov 14. Liver Int. 2012. PMID: 22099398 No abstract available.

6

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.

Gevers TJ, Chrispijn M, Wetzels JF, Drenth JP. Gevers TJ, et al. Among authors: drenth jp. BMC Nephrol. 2012 Apr 4;13:17. doi: 10.1186/1471-2369-13-17. BMC Nephrol. 2012. PMID: 22475206 Free PMC article. Clinical Trial.

7

Diagnosis and management of polycystic liver disease.

Gevers TJ, Drenth JP. Gevers TJ, et al. Among authors: drenth jp. Nat Rev Gastroenterol Hepatol. 2013 Feb;10(2):101-8. doi: 10.1038/nrgastro.2012.254. Epub 2013 Jan 8. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23296249 Review.

8

Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial.

Chrispijn M, Gevers TJ, Hol JC, Monshouwer R, Dekker HM, Drenth JP. Chrispijn M, et al. Among authors: drenth jp. J Hepatol. 2013 Jul;59(1):153-9. doi: 10.1016/j.jhep.2013.03.004. Epub 2013 Mar 14. J Hepatol. 2013. PMID: 23499726 Clinical Trial.

9

Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.

Gevers TJ, Inthout J, Caroli A, Ruggenenti P, Hogan MC, Torres VE, Nevens F, Drenth JP. Gevers TJ, et al. Among authors: drenth jp. Gastroenterology. 2013 Aug;145(2):357-65.e1-2. doi: 10.1053/j.gastro.2013.04.055. Epub 2013 May 7. Gastroenterology. 2013. PMID: 23665274

10

Evaluation of hepatic cystic lesions.

Lantinga MA, Gevers TJ, Drenth JP. Lantinga MA, et al. Among authors: drenth jp. World J Gastroenterol. 2013 Jun 21;19(23):3543-54. doi: 10.3748/wjg.v19.i23.3543. World J Gastroenterol. 2013. PMID: 23801855 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

657 results

Search Page

Filters